Outcomes Hematological parameters | Model 1 HR (95% CI) | Model 2 HR (95% CI) | C-statistica (AUC) | Relative IDIa (%) |
---|---|---|---|---|
Total CV events (n = 212) |  |  | 0.725 (0.684–0.765) |  |
 Haemoglobin | 0.79 (0.55–1.15) | 0.88 (0.61–1.29) | – | – |
 RDW | 1.06 (0.75–1.48) | 1.07 (0.76–1.52) | – | – |
 Leukocytes | 1.16 (0.83–1.63) | 0.90 (0.63–1.27) | – | – |
 Neutrophyls | 1.26 (0.89–1.76) | 1.08 (0.76–1.53) | – | – |
 Lymphocytes | 0.80 (0.58–1.13) | 0.66 (0.46–0.94)‡ | 0.728§ | 4.6%§ |
 Monocytes | 1.17 (0.83–1.63) | 0.93 (0.66–1.33) | – | – |
 Platelets | 1.16 (0.82–1.66) | 1.12 (0.78–1.60) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.55 (1.11–2.16)†| 1.47 (1.04–2.07)‡ | 0.729§ | 5.4%§ |
 Lymphocyte-to-monocyte ratio | 0.79 (0.55–1.13) | 0.87 (0.60–1.26) | – | – |
 Platelet-to-lymphocyte ratio | 1.44 (1.03–2.01)‡ | 1.50 (1.06–2.12)‡ | 0.729§ | 4.6%§ |
 Monocyte-to-HDL ratio | 1.31 (0.93–1.83) | 1.04 (0.72–1.50) | – | – |
Major CV events (n = 174) |  |  | 0.716 (0.673–0.760) |  |
 Haemoglobin | 0.74 (0.49–1.10) | 0.75 (0.50–1.14) | – | – |
 RDW | 1.07 (0.74–1.55) | 1.10 (0.76–1.61) | – | – |
 Leukocytes | 1.30 (0.89–1.90) | 1.02 (0.69–1.52) | – | – |
 Neutrophyls | 1.24 (0.85–1.80) | 1.08 (0.74–1.59) | – | – |
 Lymphocytes | 0.88 (0.60–1.27) | 0.74 (0.50–1.10) | – | – |
 Monocytes | 1.21 (0.83–1.76) | 0.96 (0.64–1.43) | – | – |
 Platelets | 1.23 (0.83–1.82) | 1.23 (0.83–1.83) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.32 (0.93–1.88) | 1.21 (0.84–1.75) | – | – |
 Lymphocyte-to-monocyte ratio | 0.82 (0.56–1.20) | 0.90 (0.61–1.34) | – | – |
 Platelet-to-lymphocyte ratio | 1.40 (0.97–2.02) | 1.48 (1.01–2.16)‡ | 0.721§ | 6.2%§ |
 Monocyte-to-HDL ratio | 1.45 (0.99–2.11) | 1.15 (0.76–1.75) | – | – |
CV mortality (n = 131) |  |  | 0.716 (0.668–0.765) |  |
 Haemoglobin | 0.83 (0.52–1.32) | 0.85 (0.52–1.37) | – | – |
 RDW | 1.43 (0.91–2.22) | 1.45 (0.92–2.27) | – | – |
 Leukocytes | 1.24 (0.80–1.91) | 0.99 (0.63–1.54) | – | – |
 Neutrophyls | 1.25 (0.81–1.92) | 1.11 (0.71–1.72) | – | – |
 Lymphocytes | 0.77 (0.50–1.18) | 0.63 (0.40–0.99)‡ | 0.719§ | 4.1%§ |
 Monocytes | 1.20 (0.78–1.85) | 0.94 (0.59–1.48) | – | – |
 Platelets | 0.93 (0.58–1.48) | 0.90 (0.56–1.44) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.39 (0.93–2.07) | 1.33 (0.88–2.02) | – | – |
 Lymphocyte-to-monocyte ratio | 0.60 (0.38–0.95)‡ | 0.62 (0.39–1.00) | – | – |
 Platelet-to-lymphocyte ratio | 1.53 (0.99–2.35) | 1.64 (1.06–2.56)‡ | 0.723§ | 8.2%§ |
 Monocyte-to-HDL ratio | 1.56 (1.00–2.44)‡ | 1.22 (0.75–1.98) | – | – |
All-cause mortality (n = 264) |  |  | 0.755 (0.717–0.793) |  |
 Haemoglobin | 0.70 (0.50–0.98)‡ | 0.76 (0.54–1.07) | – | – |
 RDW | 1.10 (0.82–1.49) | 1.09 (0.80–1.48) | – | – |
 Leukocytes | 1.18 (0.87–1.60) | 1.00 (0.73–1.36) | – | – |
 Neutrophyls | 1.17 (0.86–1.60) | 1.08 (0.79–1.48) | – | – |
 Lymphocytes | 0.66 (0.49–0.90)†| 0.58 (0.42–0.80)* | 0.758§ | 2.6%§ |
 Monocytes | 1.37 (1.01–1.86)‡ | 1.15 (0.83–1.58) | – | – |
 Platelets | 1.11 (0.80–1.52) | 1.08 (0.79–1.50) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.45 (1.08–1.96)‡ | 1.36 (1.00–1.85)‡ | 0.756§ | 0.5%§ |
 Lymphocyte-to-monocyte ratio | 0.56 (0.40–0.76)* | 0.59 (0.43–0.83)†| 0.759§ | 5.3%§ |
 Platelet-to-lymphocyte ratio | 1.39 (1.03–1.87)‡ | 1.43 (1.05–1.94)‡ | 0.756§ | 0.5%§ |
 Monocyte-to-HDL ratio | 1.48 (1.09–2.01)‡ | 1.20 (0.86–1.68) | – | – |